Cargando…
LRRK2 levels in immune cells are increased in Parkinson’s disease
Mutations associated with leucine-rich repeat kinase 2 are the most common known cause of Parkinson’s disease. The known expression of leucine-rich repeat kinase 2 in immune cells and its negative regulatory function of nuclear factor of activated T cells implicates leucine-rich repeat kinase 2 in t...
Autores principales: | Cook, D. A., Kannarkat, G. T., Cintron, A. F., Butkovich, Laura M., Fraser, Kyle B., Chang, J., Grigoryan, N., Factor, S. A., West, Andrew B., Boss, J. M., Tansey, M. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459798/ https://www.ncbi.nlm.nih.gov/pubmed/28649611 http://dx.doi.org/10.1038/s41531-017-0010-8 |
Ejemplares similares
-
Common genetic variant association with altered HLA expression, synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case–control study
por: Kannarkat, G T, et al.
Publicado: (2015) -
α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis
por: Butkovich, Laura M., et al.
Publicado: (2018) -
LRRK2 at the Interface Between Peripheral and Central Immune Function in Parkinson’s
por: Wallings, Rebecca L., et al.
Publicado: (2020) -
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Herrick, Mary K., et al.
Publicado: (2021) -
LRRK2 regulation of immune-pathways and inflammatory disease
por: Wallings, Rebecca L., et al.
Publicado: (2019)